<table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" id="tbl1" position="float"><object-id pub-id-type="doi">10.7554/eLife.20532.004</object-id><label>Table 1.</label><caption><p>Baseline characteristics of GALA II participants with methylation data, stratified by ethnicity. Continuous variables are reported with inter-quartile range in brackets.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.20532.004">http://dx.doi.org/10.7554/eLife.20532.004</ext-link></p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th><p><bold>Mexican</bold></p> </th><th><p><bold>Puerto rican</bold></p> </th><th><p><bold>Mixed latino</bold></p> </th><th><p><bold>Other latino</bold></p> </th></tr></thead><tbody><tr><td><p>n</p></td><td><p>276</p></td><td><p>220</p></td><td><p>16</p></td><td><p>61</p></td></tr><tr><td><p>Males (%)</p></td><td><p>125 (45.3%)</p> </td><td><p>127 (57.7%)</p> </td><td><p>6 (37.5%)</p> </td><td><p>28 (45.9%)</p> </td></tr><tr><td><p>Age</p></td><td><p>11.4 [9.3: 14.7]</p></td><td><p>12.3 [10.4: 14.2]</p></td><td><p>11.8 [10.7: 14.9]</p></td><td><p>11.8 [10: 15.7]</p></td></tr><tr><td><p>Asthma cases (%)</p></td><td><p>124 (44.9%)</p> </td><td><p>147 (66.8%)</p> </td><td><p>9 (56.3%)</p> </td><td><p>31 (50.8%)</p> </td></tr><tr><td/><td colspan="4"><p><bold>Ancestry (n&#160;=&#160;524)</bold></p> </td></tr><tr><td><p>African</p></td><td><p>4.3%</p> <p>[2.9%: 6.0%)</p></td><td><p>22.8%</p> <p>[16.6%: 29.4%)</p></td><td><p>8.5%</p> <p>[5.6%: 19.2%)</p></td><td><p>12.3%</p> <p>[6.3%: 25.8%)</p></td></tr><tr><td><p>Native <bold>American</bold></p> </td><td><p>55.4%</p> <p>[44.5%: 65.7%)</p></td><td><p>11.2%</p> <p>[9.8%: 13%)</p></td><td><p>31.5%</p> <p>[20.9%: 45.6%)</p></td><td><p>32.8%</p> <p>[10.4%: 49.3%)</p></td></tr><tr><td><p>European</p></td><td><p>40.5%</p> <p>[29.9%: 50.2%)</p></td><td><p>65.7%</p> <p>[59.2%: 71%)</p></td><td><p>50.5%</p> <p>[44.6%: 57.6%)</p></td><td><p>48.9%</p> <p>[40%: 58.5%)</p></td></tr><tr><td/><td colspan="4"><p><bold>Recruitment Site</bold></p> </td></tr><tr><td><p>Chicago</p></td><td><p>140 (50.7%)</p> </td><td><p>15 (6.8%)</p> </td><td><p>11 (68.9%)</p> </td><td><p>15 (24.6%)</p> </td></tr><tr><td><p>New York</p></td><td><p>18 (6.5%)</p> </td><td><p>10 (4.5%)</p> </td><td><p>1 (6.3%)</p> </td><td><p>23 (37.7%)</p> </td></tr><tr><td><p>Puerto Rico</p></td><td><p>0</p></td><td><p>193 (87.7%)</p> </td><td><p>0</p></td><td><p>0</p></td></tr><tr><td><p>San Francisco</p></td><td><p>78 (28.3%)</p> </td><td><p>0</p></td><td><p>2 (12.5%)</p> </td><td><p>23 (37.7%)</p> </td></tr><tr><td><p>Houston</p></td><td><p>40 (14.5%)</p> </td><td><p>2 (0.9%)</p> </td><td><p>2 (12.5%)</p> </td><td><p>5 (8.2%)</p> </td></tr><tr><td/><td colspan="4"><p><bold>Cell Counts (estimated)</bold></p> </td></tr><tr><td><p>Granulo cytes</p></td><td><p>51.2%</p> <p>[46.0%: 55.7%)</p></td><td><p>51.6%</p> <p>[46.8%: 57%)</p></td><td><p>51%</p> <p>[43.6%: 57.2%)</p></td><td><p>49.1%</p> <p>[43.8%: 55.8%)</p></td></tr><tr><td><p>Lympho cytes</p></td><td><p>41.9%</p> <p>[36.9%: 46.6%)</p></td><td><p>41.8%</p> <p>[36.9%: 46.5%)</p></td><td><p>41.9%</p> <p>[36.1%: 51.6%)</p></td><td><p>43.9%</p> <p>[36.8%: 49.6%)</p></td></tr><tr><td><p>Mono cytes</p></td><td><p>7.1%</p> <p>[5.8%: 8.3%)</p></td><td><p>6.74%</p> <p>[5.74%: 8.24%)</p></td><td><p>6.6%</p> <p>[5.7%: 7.6%)</p></td><td><p>7.4%</p> <p>[6.2%: 8.6%)</p></td></tr></tbody></table></table-wrap>